Pharma

Your Article Summary

See Latest Articles

GSK provides update on regulatory filings for Zunrisa/Rezonic
GlaxoSmithKline, 09/29/09

GlaxoSmithKline has made the difficult decision to discontinue the regulatory filings for Zunrisa/Rezonic, which was being developed for chemotherapy–induced and post–operative nausea and vomiting. Regulatory applications were filed in a number of countries worldwide and GSK is currently communicating with those authorities and all study investigators.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Tricare contracts may be re-bid after losing plans protest
American Medical News , 11/25/09

GSK Regulatory Update: Avodart
GlaxoSmithKline, 11/24/09

Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09

 See all of Regulatory Issues

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09

Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09

 See all of Research & Development